TELA Bio Overview

  • Founded
  • 2012

Founded
  • Status
  • Public

  • Employees
  • 147

Employees
  • Stock Symbol
  • TELA

Stock Symbol
  • Share Price
  • $8.52

  • (As of Monday Closing)

TELA Bio General Information

Description

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.

Contact Information

Website
www.telabio.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Stock Exchange
NAS
Primary Office
  • 1 Great Valley Parkway
  • Suite 24
  • Malvern, PA 19355
  • United States
+1 (484) 000-0000

TELA Bio Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TELA Bio Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.52 $8.52 $5.15 - $14.00 $163M 19.2M 75.1K -$2.78

TELA Bio Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 101,048 163,325 166,268 312,493
Revenue 34,665 29,463 18,213 15,446
EBITDA (35,760) (29,144) (24,705) (18,234)
Net Income (40,488) (33,276) (28,794) (22,425)
Total Assets 51,333 62,544 86,458 67,922
Total Debt 39,953 31,491 30,827 30,243
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TELA Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TELA Bio‘s full profile, request access.

Request a free trial

TELA Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore TELA Bio‘s full profile, request access.

Request a free trial

TELA Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of
Surgical Devices
Malvern, PA
147 As of 2022
00000
00000000 00000

000000

oris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000000000000
Marietta, GA
000 As of 0000
00000
000000000 00000

000 00

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
00000000 0000000
Kfar Saba, Israel
00 As of 0000
000.00
0.00 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TELA Bio Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mimedx Corporation Marietta, GA 000 00000 000000000 00000
000 00000 Formerly VC-backed Kfar Saba, Israel 00 000.00 000000&0 000.00
00000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 00000000000 00000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000 - 000 00000
You’re viewing 5 of 16 competitors. Get the full list »

TELA Bio Patents

TELA Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200281707-A1 Textured medical textiles Active 08-Mar-2019 00000000000
EP-3934575-A1 Textured medical textiles Pending 08-Mar-2019 00000000000
US-11446130-B2 Textured medical textiles Active 08-Mar-2019 0000000000 000
EP-3761963-A1 Surgical repair graft Pending 09-Mar-2018 000000000
EP-3761963-A4 Surgical repair graft Pending 09-Mar-2018 A61L27/52
To view TELA Bio’s complete patent history, request access »

TELA Bio Executive Team (16)

Name Title Board Seat Contact Info
Antony Koblish Co-Founder, Chief Executive Officer & President
Roberto Cuca JD Chief Financial Officer & Chief Operating Officer
Paul Talmo Chief Strategy Officer, Strategy
Ellis Greenhalgh Chief Technology Officer, Technology
Megan Smeykal Chief Accounting Officer, Accounting & Controller, Finance
You’re viewing 5 of 16 executive team members. Get the full list »

TELA Bio Board Members (12)

Name Representing Role Since
Douglas Evans Self Board Member 000 0000
John Nosenzo Self Board Member 000 0000
Kevin Rakin HighCape Capital Board Member 000 0000
Kourosh Azarbarzin Self Chairman 000 0000
Kurt Azarbarzin TELA Bio Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

TELA Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TELA Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore TELA Bio‘s full profile, request access.

Request a free trial